Canada Pharmacies Worried About Increased Cancer Screening Without Benefits

Potential benefits of screening tests have never been ascertained. Senior citizens, however, are not deterred by existing uncertainty and prefer undergoing routine tests to detect cancer. Canada pharmacies find most men in the age group of 75 to 79 years opt for prostate cancer screenings.

Over 50% women in the 75- to 79-year age group underwent Pap smear tests for cervical cancer detection or underwent breast cancer screening. The fact was results did not make a massive difference in the number of people opting for the screening tests.

Earlier results have already shown most screening tests appear to have substantial negative effects, except for a few like colonoscopy or mammography being able to save lives. It was precisely why older people were not advised to undergo screening tests. Limited data was available over a period of time, which is why the current study is vital in understanding results in more depth.

Findings indicate benefits of screening are more evident in young adults. Results indicate medical complications surpass benefits as people age. In other words, more disadvantages are seen in older patients opting for a medical procedure. Among the several disadvantages is the cost involved in undergoing the tests. The concept of “over diagnosis” is quite evident when it comes to screening tests. Experts now determine a minimum survival rate of five years is warranted, if patients are to opt for them.

Intolerance to drugs and stringent treatment plans is another aspect to be considered, especially among older patients. They may be unable to survive rigorous medical tests. Forgoing the tests may be a better option leading to a higher survival rate, according to Canada pharmacies.

Over 4,000 American citizens over the age of 75 years formed the volunteer group leading to the results. They were earlier interviewed between the years 2005 and 2008 during the National Health Interview Survey.

About 57% senior men were screened for colon cancer, and 56% were screened for prostate cancer in the year 2010. A higher percentage of women did not consider historical data as was evident by 62% results in the same 75- to 79-year group. Around 53% women had undergone screening for cervical cancer over the past three years.

Precise reasons for people undergoing tests were not covered in the study, which made it difficult for creating a standard in terms of benefits surpassing drawbacks in particular age groups for screening of chronic illnesses like cancer.

For instance, the American Cancer Society does not specify an upper age limit for screening but suggests a minimum of 10 years life expectancy for people undergoing prostate cancer screening. The US Preventive Services Task Force, on the other hand, is against routine screening tests for cancer in people over 75 years old citing insufficient evidence to support both benefits and disadvantages.

Some people in the older age group seem to gather more health benefits while others develop complications having undergone the same medical process. The uncertainties have therefore made it practically impossible for regulatory bodies to confirm both benefits as well as disadvantages.

Canada pharmacies are convinced further research and debates are needed to convince majority of doctors treating cancer patients to reconsider recommendations for elderly patients in light of the recent study.

Alice Wolfe is specializing in writing articles on how to save on medication by buying from canadian pharmacy. For more information about the author and savings on canadian pharmacies online please visit http://www.canadapharmacyonline.com